![Magnus Tägil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Magnus Tägil is the founder and currently holds the title of Director at Moroxite AB, which is founded in 2020.
Posizioni attive di Magnus Tägil
Società | Posizione | Inizio |
---|---|---|
Moroxite AB
![]() Moroxite AB Pharmaceuticals: MajorHealth Technology Moroxite AB is a medtech company based in Lund, Sweden, with subsidiaries in Sweden. Moroxite is developing a portfolio of breakthrough therapies in targeted drug delivery, using innovative nano and micro technology-based platforms. The Swedish company's focus areas include bone regeneration, tumor, and bone infection. The private company has developed a platform for prolonged release of apatite binding drugs, using a carrier containing nano and micro particles. Recently, Moroxite spun-off its bone infection and fracture fixation businesses into independent companies, Moroxite I AB and Moroxite F AB, respectively. Moroxite F AB has raised capital of 10 MSEK in a private placement from two investors, Fåhraeus Startup & Growth and Almi Invest. The company was founded in 2020 by Lars Ã…ke Alvar Lidgren, Magnus Tägil, and Deepak Raina. | Fondatore | 01/01/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Moroxite AB
![]() Moroxite AB Pharmaceuticals: MajorHealth Technology Moroxite AB is a medtech company based in Lund, Sweden, with subsidiaries in Sweden. Moroxite is developing a portfolio of breakthrough therapies in targeted drug delivery, using innovative nano and micro technology-based platforms. The Swedish company's focus areas include bone regeneration, tumor, and bone infection. The private company has developed a platform for prolonged release of apatite binding drugs, using a carrier containing nano and micro particles. Recently, Moroxite spun-off its bone infection and fracture fixation businesses into independent companies, Moroxite I AB and Moroxite F AB, respectively. Moroxite F AB has raised capital of 10 MSEK in a private placement from two investors, Fåhraeus Startup & Growth and Almi Invest. The company was founded in 2020 by Lars Ã…ke Alvar Lidgren, Magnus Tägil, and Deepak Raina. | Health Technology |
- Borsa valori
- Insiders
- Magnus Tägil